Hepatitis B Tests Industry - Regional Synopsis
Asia Pacific industry is anticipated to account for largest revenue share by 2037, backed by large number of patients, and growing occurrence of hepatitis in the region, backed by large number of patients, and growing occurrence of hepatitis in the region. Moreover, the market in North America is expected to grab the largest share during the forecast period, which can be credited largely to the high availability of advanced diagnostic tools in the region. In addition, increasing number of government initiatives to raise awareness about hepatitis, and high healthcare expenditure are also projected to drive the market growth in the region in the coming years. As per the Centers for Medicare & Medicaid Services (CMS), the healthcare spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion. As a share of the nation’s Gross Domestic Product (GDP), the health spending accounted for about 19.7%.
